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Abstract
The MUC2 mucin is the major constituent of the two mucus layers in colon. Mice lacking the disulfide isomerase-like protein
Agr2 have been shown to be more susceptible to colon inflammation. The Agr22/2 mice have less filled goblet cells and
were now shown to have a poorly developed inner colon mucus layer. We could not show AGR2 covalently bound to
recombinant MUC2 N- and C-termini as have previously been suggested. We found relatively high concentrations of Agr2 in
secreted mucus throughout the murine gastrointestinal tract, suggesting that Agr2 may play extracellular roles. In tissue
culture (CHO-K1) cells, AGR2 is normally not secreted. Replacement of the single Cys in AGR2 with Ser (C81S) allowed
secretion, suggesting that modification of this Cys might provide a mechanism for circumventing the KTEL endoplasmic
reticulum retention signal. In conclusion, these results suggest that AGR2 has both intracellular and extracellular effects in
the intestine.
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Introduction
The gastrointestinal tract is protected by mucus that is
differently organized along the intestine [1]. In the small intestine
there is a single mucus layer, whereas mucus in the stomach and
colon is double layered. In colon the inner mucus layer is
important for separating bacteria from the epithelium [2]. Defects
in this inner mucus layer allow bacteria to get in contact with the
epithelial cells, an event which can trigger an inflammatory
reaction [3,4]. The MUC2 mucin forms the skeleton of the
intestinal mucus [4]. This gel-forming mucin is thus instrumental
in maintaining a functional inner colon mucus layer, and its
absence leads to severe colitis and cancer development [2,5]. This
places the goblet cells, which biosynthesize the MUC2 mucin, in
the focus of understanding mucus.
Anterior gradient 2 protein (AGR2) is part of the three
membered AGR family first identified to be involved in control
of the cement gland and brain development of Xenopus [6]. In
salamanders anterior gradient-related proteins Nag and Mag
induce the spectacular regeneration of lost vertebrate limbs [7]. In
mammalian breast tissue AGR2 expression is estrogen controlled
and regulates mammary epithelial proliferation [8]. Thus AGR
proteins have growth promoting effects, a property that is linked to
the role of AGR2 in cancer development and metastasis of several
tumor types [9]. AGR2 is proposed to act as a pro-oncogene as
well as regulating cell proliferation [8,9]. The Xenopus and
Salamander mechanisms are due to secreted forms of the AGR-
analogues, but the localization of the growth promoting effect in
mammals is less understood [9]. Recent studies using recombinant
monomeric AGR2 suggested that it could bind on the outside of
cells suggesting that AGR2 could have an extracellular effect [10].
Mature AGR2 is a small 154 amino acid protein with a single
central Cys residue and a non-conventional endoplasmic reticu-
lum (ER) retention motif (KTEL). The structure of AGR2 was
recently revealed and suggested that AGR2 was appearing as a
non-covalent dimer in the ER [10]. The Cys residue is part of the
CXXS motif that is found in the large family of disulfide
isomerases (PDI) and as many members of these proteins also have
ER-retention signals, AGR2 have been suggested to act as a PDI
and being involved in controlling ER homeostasis [11]. Such a
function is supported by the observation that AGR2 can act as a
protein disulfide isomerase-like molecule important for MUC2
biosynthesis [12]. To further study AGR2 function, several mice
lines (Agr22/2) have been developed [12–14]. All of these animals
show alterations in different parts of the gastro-intestinal tract.
As AGR2 has been suggested to be involved in the MUC2
mucin biosynthesis we found it essential to further understand the
relation between AGR2 and MUC2 [12]. This is of further
importance as AGR2 had been genetically linked to inflammatory
bowel disease susceptibility [15]. We thus decided to analyze the
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interaction of AGR2 with the MUC2 mucin in more detail in vitro
using a cell culture model and in vivo in Agr22/2 mice. In the cell
culture model we could not confirm direct covalent binding of
AGR2 to MUC2. We also observed that AGR2 was secreted when
its single Cys was removed (C81S). Lastly, we could show that the
intestinal mucus contained a high concentration of secreted Agr2,
suggesting extracellular effects among the poorly understood
functions of this protein.
Materials and Methods
Generation of the pcDNA3.1-AGR2 plasmid
The full length cDNA sequence of the human AGR2 was PCR-
amplified from the RZPD clone IRATp970F1215D6 with the
primers 59-CACCATGGAGAAAATTCCAGTGTC-39 and 59-
CAATTCAGTCTTCAGCAACTTGAGAGC-39 to introduce a
59 CACC overhang, needed for directional cloning into the vector
pcDNA3.1D/V5-His-TOPO (Life Technologies). Next, a stop
codon was introduced in the vector after the AGR2 sequence by
site-directed mutagenesis (QuickChange site-directed mutagenesis
kit; Stratagene) using the primers 59- CTCAAGTTGCTGAA-
GACTGAATTGTAGGGTCAAGACAATTCTGCAG -39 and
59-CTGCAGAATTGTCTTGACCCTACAATTCAGTCTTC-
AGCAACTTGAG-39 (mismatch is underscored). The PCR was
initiated at 95uC for 30 s, followed by 15 cycles (95uC for 30 s,
55uC for 1 min and 10 min at 68uC with a final elongation for
10 min at 68uC.The resulting vector was designated as
pcDNA3.1-AGR2 and encoded an untagged version of the
human AGR2.
Subcloning with pcDNA3.1/Zeo(+)
To make stable clones of CHO-psNMUC2-MG [16] and
AGR2, the plasmid pcDNA3.1-AGR2 was subcloned to be
resistant against Zeocin. The AGR2-containing sequence was
excised from the pcDNA3.1-AGR2 vector with the restriction
endonucleases BamH1 and Xba1, and ligated in frame into the
pcDNA3.1/Zeo(+) vector (Life Technologies) linearized with the
same enzymes, generating the expression plasmid named
pcDNA3.1/Zeo-AGR2.
Mutagenesis of pcDNA3.1-AGR2
The mutagenesis was made through PCR reactions, digestion of
products and transformation into XL1-Blue super-competent cells
according to the QuickChange Site-Directed Mutagenesis Kit
(Stratagene). In order to create a DNA-plasmid encoding a Ser
instead of a Cys on the 81st amino acid of the protein (AGR2
C81S), the template plasmid pcDNA3.1D-AGR2 was PCR
amplified with the forward primer 59-CATCACTTGGAT-
GAGTCCCCACACAGTCAAGC-39 and the reverse primer 59-
GCTTGACTGTGTGGGGACTCATCCAAGTGATG-39. The
PCR was initiated at 95uC for 30 seconds, followed by an
annealing/elongation phase of 18 cycles (95uC for 30 seconds,
53uC for 1 minute, 6 minutes at 68uC).
To create a DNA-plasmid coding to transcribe a protein with an
Asp instead of a Thr residue at position 173 of the protein (AGR2
T173D), the template plasmid pcDNA3.1D-AGR2 was PCR
amplified with the forward primer 59-CAAGTTGCTGAAG-
GATGAATTGTAGGAGCTCGACAATTCTGC-39 and the
reverse primer 59-GCAGAATTGTCGAGCTCCTACAATT-
CATCCTTCAGCAACTTG-39. The PCR was initialized for 30
seconds at 95uC, followed by an annealing/elongation phase of 18
cycles (95uC for 30 seconds, 52uC for 1 minute, 6 minutes at
68uC).
For construction of the DNA-plasmid encoding a version of
AGR2 without the KTEL sequence (AGR2 DKTEL), the Lys
residue in the terminal KTEL peptide was replaced by a STOP
codon. pcDNA3.1D-AGR2 was PCR amplified with the forward
primer 59-CAAGTTGCTGTAGGAGCTCTTGTAGGGTCA-
AGAC-39 and the reverse primer 59-GTCTTGACCCTACAA-
GAGCTCCTACAGCAACTTG -39. The PCR conditions were
the same as for the AGR2 C81S. All generated plasmids were
controlled by nucleotide sequencing after mutagenesis.
Tissue culture
CHO-K1 cells were obtained from the American Type Culture
Collection (CCL-61) and cultured in Iscove’s modified Dulbecco’s
medium (Lonza) containing 10% (v/v) fetal bovine serum. The cell
line CHO-pSNMUC2-MG was cultured in the same medium
supplemented with G418 (250 mg/mL) [16]. Cells transfected with
pcDNA3.1/Zeo-AGR2 were additionally kept in Zeocin (Life
Technologies) (250 mg/mL).
Transfection
Transient transfections were made in CHO-K1 cells or CHO-
pSNMUC2-MG cells using to the Lipofectamine 2000. After
48 hours the supernatant was collected. The cells were then
incubated 30 min on ice with lysis-buffer containing Complete
EDTA-free protease inhibitors (Roche), and collected.
SDS-PAGE and immunoblotting
For protein separation, samples were mixed with Laemmli
sample buffer with or without 200 mM dithiothreitol (DTT),
incubated for 5 min at 95uC and separated in a 3–15%
polyacrylamide gel by discontinuous SDS-PAGE using a 3%
stacking gel [17]. The Precision Protein Standard (Bio-Rad) was
used as molecular marker. The separated proteins were Western-
blotted onto polyvinylidene difluoride (PVDF) membranes (Im-
mobilon-PSQ Transfer Membrane, Millipore) using a Trans-Blot
SD semidry transfer cell (Bio-Rad) at 2.4 mA/cm2 (MUC2) or
2.0 mA/cm2 (AGR2) for 1 h with blotting buffer (Tris 48 mM,
glycine 39 mM, SDS 1.3 mM and 10% or 20% methanol for
MUC2 and AGR2 respectively). The membrane was blocked for
1 hour at RT in 5% non-fat milk in PBS with 0.1% Tween 20,
and incubated 1 hour at RT or at 4uC overnight with the primary
monoclonal antibodies anti-AGR2 (Abnova H00010551-M01,
1:2000), anti-GFP (Sigma G6539, 1:4000) or anti-Actin (Millipore
MAB1501, 1:5000) and subsequently with a secondary goat anti-
mouse-HRP antibody (Southern Biotech 1:2000). Membranes
were developed with Immobilon Western chemiluminescent HRP
substrate (Millipore), imaged using a LAS 4000 analyzer (Fujifilm),
and the band intensities measured using the Multi Gauge v3.0
(Fujifilm) software. Band intensities of three replicated blots plotted
as histograms using GraphPad Prism v6 (GraphPad, La Jolla, CA).
Immunohistochemistry
Agr22/2 mice were kindly provided by David Erle (Univ. Calif.
San Francisco, CA) [12]. Mice were kept in individually ventilated
cages under SPF conditions, sacrificed by CO2 inhalation and
mouse numbers were reported to the regional authorities
(Veterinäramt München, Munich, Germany). These mice and
the Agr2+/+ (WT) and Agr+/2 were housed together and distal
colon tissue from these were fixed in Carnoy solution (MethaCarn)
to preserve the mucus [2]. Sections were dewaxed using Xylene
substitute (Sigma) and hydrated. The antigens were retrieved by
microwave heating in 0.01 M citric buffer pH 6.0 and the sections
AGR2 in Mucus
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were incubated with the anti-MUC2C3 antiserum 1:1,000 [2] or
anti-GpA Muc2 1:1,000 dilution [18].
For protein detection in cell lines, the selected clones were fixed
with 4% PFA, permeabilized with 0.1% Triton X-100 in PBS, and
incubated with the primary antibodies described above for AGR2
and GFP, and with the ER marker anti-calnexin (Abcam ab22595,
5 mg/mL). Alexa Fluor 488, 546 or 555-conjugated goat anti-rat,
anti-mouse or anti-rabbit IgG (Life Technologies, 1:1,000),
respectively, were used as secondary antibodies. The slides were
counterstained with DAPI (Sigma, 1:20,000) to visualize the nuclei
before mounting with Prolong Gold Antifade reagent (Life
Technologies). Pictures were obtained using an upright LSM
700 Axio Examiner 2.1 system with a Plan-Apochromat x20/0.8
DIC objective (Carl Zeiss).
Collection of murine mucus
For mucus collection, conventional C57BL/6 mice (Taconic,
in-house bred) were used with the approval of the local Laboratory
Animal Ethics Committee (Gothenburg, Sweden). Mice were
anaesthetized with isoflurane and followed by cervical dislocation.
Intestinal tissues from 6 mice (3 males and 3 females) ranging from
stomach to distal colon were mounted in a horizontal perfusion
chamber with a circular opening of 4.9 mm2 and luminal mucus
was aspirated as described previously [19].
Collection of human mucus and tissue samples
Human biopsies from control patients (individuals where no
abnormalities were reported) were collected after written consent
of the patients during routine colonoscopy at Sahlgrenska
University Hospital (Gothenburg, Sweden). The study was
approved by the Human Research Ethical Committee from the
University of Gothenburg (Sweden). Biopsies were mounted in a
horizontal perfusion chamber and the secreted mucus aspirated as
described [20]. Biopsies were then dismounted and lysed in lysis
buffer (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1% (v/v) Triton
X-100) containing Complete EDTA-free protease inhibitors
(Roche), with a Ultra-turrax T8 homogenizer (IKA).
Proteomics
The relative quantities of Agr2 along the gastrointestinal tract
were obtained from a larger proteomics study of the mucus
composition in stomach, duodenum, jejunum, ileum, and prox-
imal and distal colon [19]. The molar ratios for Agr2, Muc2,
Fcgbp and Clca1 were calculated (in fmol) by the use of the
standard peptides from that study, by normalizing the heavy/light
ratios for each peptide pair and averaging the results per protein.
Results
AGR2 does not bind MUC2, but affects ER morphology
AGR2 has been suggested to be covalently attached to the
MUC2 mucin [12]. These authors used transient transfection of
both MUC2 and AGR2 plasmids and COS-7 or HEK-293T cells.
To further address this observation in cells that stably secrete
truncated parts of MUC2, we used CHO-K1 cells that are stably
expressing the MUC2 N-termini (SNMUC2-MG) or MUC2 C-
termini (SMG-MUC2C), respectively [16,21]. These cell lines
were selected as they secrete the two MUC2 parts, something that
does not take place during transient transfections as the protein
levels are too high to allow proper processing in the endoplasmic
reticulum (ER). The CHO-K1 cells were first shown not to express
AGR2 endogenously. The two cell lines were then transiently
transfected with plasmids encoding either human AGR2 (WT),
AGR2 where the Cys at position 81 was replaced by Ser (C81S),
AGR2 sequences where the C-terminal ER retention signal KTEL
of AGR2 had been altered to the canonical ER retention signal
KDEL (T173D), or AGR2 lacking the entire KTEL retention
signal (DKTEL). Cell lysates from these transiently transfected
cells were separated on non-reducing gels allowing the MUC2N
trimer and MUC2C dimer to enter the gel. The Western blots
were immunostained with an anti-AGR2 antibody or with anti-
GFP for the MUC2N and MUC2C GFP fusion products (Fig. 1).
In these gels, we could not observe any shifts of AGR2-containing
bands larger than the AGR2 monomer. This suggests that in our
cell model, AGR2 and MUC2 do not covalently interact.
Further attempts to demonstrate an AGR2-MUC2 interaction
were made by co-immunoprecipitation using either anti-AGR2 or
anti-MUC2 antibodies on CHO-K1 cells permanently or tran-
siently expressing MUC2N or MUC2C and transfected with
AGR2. None of these experiments showed any indication of a
Figure 1. Western blot analysis detecting AGR2 in stably
MUC2N- or MUC2C-expressing CHO-K1 cells. The same number
of CHO-K1 cells were transiently transfected with equal amounts of
expression plasmids coding for human AGR2 and its mutated variants.
Equal amount lysates of MUC2N-expressing CHO-K1 cells (A) or MUC2C-
expressing CHO-K1 cells (B) had been transfected with the different
forms of AGR2, were separated by non-reducing SDS-PAGE and
immunoblotted for AGR2. Only a single band at the expected size of
AGR2 was observed, and no higher molecular bands were visible
indicating that AGR2 did not bind to the MUC2N or MUC2C proteins
expressed in the same cell line. Lysates of MUC2N- or MUC2C-
expressing CHO-K1 cells immunostained for GFP are shown to the left
and right, respectively. Figures are representative of at least 3 replicates.
Band intensities of AGR2 normalized to the strongest band (MUC2N-
C81S) in the blots of three replicates are plotted as a histogram (C) for
MUC2N (correpsonds to gel in A) and (D) for MUC2C (correppnds to gel
in B). Error bars represent standard deviation.
doi:10.1371/journal.pone.0104186.g001
AGR2 in Mucus
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non-reducible binding between AGR2 and MUC2 (results not
shown). Therefore we concluded that most likely there is no
covalent, disulfide bonded interaction between AGR2 and MUC2
in the cells used in this study.
As we could not confirm direct interaction between AGR2 and
MUC2, we further studied the effect of AGR2 in MUC2 secretion.
The CHO-K1 cell line stably expressing MUC2N was transfected
with WT AGR2, and stable clones with different AGR2
expression levels were selected. The expression levels of AGR2
were first analyzed by SDS-PAGE and Western blot (Fig. 2A).
The clone designated #9 had the lowest intracellular level of
AGR2, whereas clone #4 had the highest and clone #16
displayed an intermediate AGR2 expression level. WT AGR2 was
not secreted into the culture medium for any of these clones,
except that a small amount of AGR2 could be observed in the
clone (#4) with the highest AGR2 expression level. When the
media and lysates were probed for the stably expressed MUC2N
by detecting its GFP-tag, clone #9 showed secretion of MUC2N
as was the case for the parent non-AGR2-transfected CHO-K1
cell line (Fig. 2B). None of the two high-expressing clones (#4 and
#16) secreted any MUC2N, although all of them showed
intracellular MUC2N. This suggested, in contrast to our
hypothesis, that AGR2 did not promote folding, maturation, or
secretion of MUC2. Instead it suggested that AGR2 retained
MUC2 in the cells.
The clones #4, #9 and #16, expressing MUC2N and different
amounts of AGR2 were studied by immunofluorescence (Fig. 3) of
MUC2N (red) and AGR2 (green). The levels of AGR2 varied from
lowest to highest in the order #9,#16#,#4, as shown by
Western blot (Fig. 2A). In relation to AGR2, the clones displayed
increased and aberrant intracellular staining of MUC2N and
especially clone #4 showed cells with an increased nuclear
volume. As MUC2N accumulates in the ER, this observation
suggests that AGR2 affected both ER structure and function.
These results also made it less likely that AGR2 have any effect in
promoting MUC2 maturation and secretion and suggest instead a
more general effect on ER function.
Agr22/2 mice lack the colonic inner mucus layer
The distal colon of Agr2+/+, Agr2+/2, and Agr22/2 mice was
fixed in Carnoy’s solution and stained for mature Muc2 (Fig. 4,
two upper panels). In the Agr2+/+ and Agr2+/2 animals, a typical
inner mucus layer was observed that lacked bacteria (stained as
small blue dots). However, in the Agr22/2 mice this inner layer
was almost absent and DNA-staining most likely representing
bacteria could be found in all mucus and sometimes in contact
with the epithelial cells as shown by arrows in Fig. 4, middle panel.
Staining for Muc2 showed filled goblet cells, although at a lower
level in Agr22/2 than in the Agr2+/2 and Agr2+/+ animals.
When the colonic tissues were stained with an antiserum against
the non-O-glycosylated form of Muc2 (the ER-localized precursor
of the molecule), the Agr2+/+ tissue was stained as typical ER
(Fig. 4, lower two panels). However, the patterns in the Agr22/2
tissues were more intense and considerably more punctuated
resembling a more fragmented ER. Together this shows that
Muc2 is formed in the Agr22/2 mice, but the amounts eventually
processed and secreted might be insufficient to form a functional
mucus layer.
Agr2 is secreted and found abundantly in the
gastrointestinal mucus
In studies of the mouse colonic mucus by proteomics Agr2 was
observed to be a relatively abundant protein [2,22]. We have now
expanded our mucus proteomic studies to the whole gastro-
Figure 2. Western blot analysis of CHO-K1 cells stably
expressing MUC2N and stably variable levels of AGR2. (A)
Spent culture media and lysates normalized to similar number of cells
were immunoblotted using an anti-AGR2 antibody after reducing SDS-
PAGE. Notice that bands blighted in the center have the highest
concentration of AGR2. The stable clones showed varying amounts of
AGR2 (#9,#16,#4). Band intensities of AGR2 normalized to the
strongest band (clone #4) in the blots of three replicates are ahown as
AGR2 in Mucus
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intestinal tract and observed that Agr2 was present in the mucus
of all parts of the digestive tract reaching the highest concentra-
tions in the proximal colon (Fig. 5A). To further confirm the
extracellular localization of also the human AGR2, colonic
mucus from human biopsies was carefully collected after
mounting it in a horizontal Ussing-type chamber, and both the
collected mucus and the remaining intestinal tissue were analyzed
by PAGE and Western blot. An AGR2 band at about 18 kDa
was found in the collected mucus as well as in the colon tissue
(Fig. 5B). It can thus be concluded that both the human AGR2
and the murine Agr2 are not only resident ER proteins, but they
are also present in significant amounts in the secreted gastroin-
testinal mucus.
The molar amounts of Agr2 in mouse mucus were further
analyzed by proteomics in relation to known abundant mucus
proteins (Muc2, Fcgbp, and Clca1) by adding internal heavy
peptide standards during mass spectrometry analyses of the
collected mucus [19]. The molar ratios for these four proteins
were relatively similar (Fig. 5C). In fact, as Agr2 was suggested to
be the most abundant further support the idea that Agr2 is
secreted and may have also extracellular functions.
AGR2 is retained in the ER by its single Cys amino acid
and the KTEL sequence
The murine Agr2 and the human AGR2 were found in
considerable amounts in the intestinal mucus, despite the presence
of the non-typical ER retention signal KTEL in their C-termini.
AGR2 expressed in CHO-K1 cells was also retained in the ER
and not secreted (see Fig. 6D). To clarify these discrepancies,
CKO-K1 cells were transiently transfected with plasmids encoding
human WT AGR2, AGR2 with its Cys81 replaced by Ser (C81S),
AGR2 with its C-terminal KTEL altered to KDEL (T173D), or
AGR2 without its C-terminal KTEL (DKTEL). Proteins from the
cell lysates were separated by reducing PAGE and AGR2 detected
by Western blot (Fig. 6A–B). All the AGR2 protein variants were
detected in the cell lysates (Fig. 6). However, only the C81S and
DKTEL AGR2 forms were found in the spent culture media. That
the DKTEL was not retained has been shown before and was thus
expected [23]. However, that its single Cys was involved in
controlling ER exit has not been observed previously. The results
suggest a specific functional coupling between the ER retaining
KTEL signal and the single free Cys for AGR2 retention.
Discussion
The importance of AGR2 for a proper mucin and mucus
formation was proven previously [12]. These Agr22/2 mice
showed despite this little colonic inflammation, but DSS (Dextran
Sodium Sulfate) challenge gave a more severe inflammatory
phenotype than in control animals. The increased DSS suscepti-
bility of Agr22/2 mice were further illustrated and explained by
our observed lack of a typical inner mucus layer. Our previous
studies have shown that a well-functional inner colon mucus layer
is necessary for separating the bacteria from the epithelial cells and
a histogram in Fig. S1. (B) Immunoblot with an anti-GFP antibody
detecting the MUC2N protein using the same media and lysates as in
(A). In the lysates MUC2 was largely found as the not fully glycosylated
form (lower band, slightly below 250 kDa). The mature glycosylated
form of MUC2 (higher band, above 250 kDa) was found in the media
from the control sample (MUC2N) and clone #9 (MUC2N AGR2 #9).
Figure is representative of at least 3 replicates.
doi:10.1371/journal.pone.0104186.g002
Figure 3. AGR2 alters the morphology of the ER. Immunostaining of the stable MUC2N and AGR2 expressing CHO-K1 cells (see
Fig. 2). Parent CHO-K1 cells stably expressing various amounts of AGR2 (green) show an increased accumulation of MUC2N and a more severely
altered cell morphology depending on the level of AGR2 (clone #9,#16,#4, see Fig. 2). Nuclei are stained in blue with DAPI. Scale bar: 50 mm. For
quantitative comparisons, see Fig. 2. Figures are representative of at least 3 replicates.
doi:10.1371/journal.pone.0104186.g003
AGR2 in Mucus
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that bacteria in massive contact with the epithelium trigger
inflammation [2,3,24]. Although no typical inner mucus layer was
observed in the Agr22/2 mice, these mice still secreted Muc2
mucin as observed by immunostaining. This remaining secretion
did not form a proper mucus layer, but still was sufficient to keep
the crypts free of bacteria. No bacteria were found inside the
epithelial cells as observed for the Muc22/2 mice. The Agr22/2
goblet cell granulae was less filled with mature Muc2 compared to
WT mice, but there seemed to be sufficiently mucin secreted to
maintain a steady mucus flow to move bacteria away from the
epithelial cells. However, further challenging with DSS suggested
that the Agr22/2 mice had more difficulties in handling bacterial
stress [12], something that is well in line with a less developed
inner mucus layer.
In this work, we could not confirm the previous observation of a
direct binding of the AGR2 and the MUC2 N- or C-terminal
protein fragments [12]. Although the MUC2 plasmids used were
the same as in the previous study, a reason for this discrepancy
could be the different cell lines used. In this case, we employed
CHO-K1 cells stably secreting the MUC2 proteins, as we know
that transient transfection of the corresponding plasmids induce
such a high expression level that most of the MUC2 proteins
(especially the N-terminal end) accumulates in the ER. It is only in
stable expressing cell lines with lower mRNA and protein levels
that secretion is observed. The high number of Cys in MUC2
could be an attractive explanation for why AGR2 was previously
observed to bind covalently to MUC2, as this could bind free Cys
in MUC2. In the previous study [12], the binding between AGR2
and MUC2 was only observed intracellular and might be due to
non-specific binding due to overexpression. The domain organi-
zation and the localization of the Cys in MUC2 is almost identical
to that of the von Willebrand factor [25], a protein that evolved
from metazoan mucin-like proteins [26]. However, AGR2 is not
expressed in endothelial cells (http://www.proteinatlas.org) that
synthesize the von Willebrand factor, suggesting that AGR2 is not
necessary for maturation of this molecule. This further argues
against AGR2 being absolutely necessary for MUC2 biosynthesis
and secretion.
Figure 4. Immunostaining of sections from distal colon from
Agr2+/+ (+/+) n = 5, Agr2+/2 (+/2) n = 2, and Agr22/2 (2/2) n = 3
mice, two sections of each mouse were stained and examined.
Two sections each of all Agr22/2 animals are shown in Fig. S2. The two
upper panels display two sections each for the mature Muc2 (detected
with anti-MUC2C3 antiserum, green) using a glycosylation independent
antiserum (the gap between the inner mucus layer and the epithelium
is due to shrinking during processing). A decreased amount of mature
Muc2 stored in the mucin granules can be observed in the Agr22/2
mice. The middle panel with the DAPI channel alone most likely show
bacteria stained as the smallest dots close to the epithelium in the
Agr22/2 mice as indicated by arrows. The larger blue dots further away
from the epithelium are shed cells or fecal content. The two lower
panels show sections at two magnifications stained with an antiserum
against the nonO-glycosylated Muc2 precursor (anti-gpA antiserum,
green) found in the ER. A more fragmented ER with accumulation of
immature Muc2 is observed in the Agr22/2 mice. DNA stained with
DAPI (blue). Scale bar 25 mm for the top three panels, scale bar 10 mm
for the lowest panel.
doi:10.1371/journal.pone.0104186.g004
Figure 5. Agr2 is a component of the protective mucus layer in
the whole gastrointestinal tract. (A) Boxplot of the relative levels
(logarithm of the normalized intensities) of Agr2 in the mucus along the
mouse gastrointestinal tract as revealed by proteomics. Sto: stomach;
Duo: duodenum; Jej: jejunum; Ile: Ileum; PC: proximal colon; DC: distal
colon. (B) Immunoblot detecting AGR2 in mucus from human colonic
biopsies mounted in a horizontal perfusion hamber. The first lane
(mucus) contains the collected secreted mucus. The second lane (lysate)
shows the AGR2 remaining in the biopsy after mucus collection (diluted
1:100). (C) Molar ratios between Agr2, Muc2, Fcgbp and Clca1 in
proximal and distal colonic murine mucus.
doi:10.1371/journal.pone.0104186.g005
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Several Agr22/2 mouse lines have been generated and found to
have variable defects in different organs [12–14]. In particular,
Park et al. showed an almost complete absence of goblet cells in
the small and large intestine [12], something that we could not
observe in this study using the same Agr22/2 mouse strain. A
number of reasons for this difference could be envisioned as
different bacteria found in the mouse housing facilities, different
ages of the mice, different anti-Muc2 antibodies, or different levels
of inflammation. It is well known that inflammation can trigger
goblet cell secretion and emptying of the goblet cells and by this
give the impression of lost goblet cells. Zhao et al. also observed
less intestinal goblet cells in another Agr22/2 mice line, using both
a germ-line knock-out as wells as an inducible deletion [13]. They
also observed atypical and abnormally filled Paneth cells. The
Paneth cells produce antibacterial peptides, lysozyme and are also
producing and secreting MUC2 mucin. Thus AGR2 not only
triggers goblet cell emptying, but also accumulation in Paneth cell
granulae further arguing for AGR2 having a more complex
function that are dependent on cell type. These mice displayed
both severe spontaneous colitis and ileitis, whereas the ones from
Park et al. required a DSS challenge to present a more severe
phenotype than the WT controls. Finally, Gupta et al. studied the
stomach of yet another Agr22/2 mouse line and demonstrated a
remarkable mucosa hyperplasia of the glandular stomach, giving
rise to stomach outlet obstruction [14]. From these results one can
conclude that lack of Agr2 leads to different outcome of different
cell types, something that obscures an understanding of AGR2
function.
AGR2 has a large effect on the ER as has been suggested in a
number of articles [11–13,23]. However, the mechanism and
functional effect of AGR2 is not understood, but AGR2 have both
morphological and functional effects on the ER. We could also
show that loss of Agr2 leads to a fragmented ER and that
overexpression gives rise to an enlarged ER. Overexpressing
AGR2 in CHO-K1 cells already secreting MUC2N caused
decreased MUC2N secretion suggesting that AGR2 did not
facilitate MUC2N processing.
The function of AGR2 in the ER is still not understood. The
structure of AGR2 recently revealed that AGR2 forms a non-
covalent dimer in solution [10]. This dimer is formed based on
non-covalent charge interactions and not by any disulfide-bond
interactions. This dimer is unstable and requires artificial cross-
linking to be observed something that explains why we have never
observed AGR2 dimers [27]. This non-covalent dimeric form of
AGR2 might be important for its ER function [27]. Interestingly,
the structural work also suggested that cell binding only required
monomeric AGR2 [10], supporting the idea that AGR2 may also
have extracellular functions.
That the AGR2 C-terminal KTEL ER retention motif has a
special function that is different from the more typical KDEL has
already been suggested [23]. AGR2 expression in cancer cells
induces the expression of amphiregulin (AREG) and in intestinal
IEC-6 cells the transcription factor CDX2 [23,28]. Interestingly,
replacing the KTEL with KDEL made AGR2 incapable of
inducing CDX2 expression although AGR2 were still retained in
the ER [23]. The importance of the KTEL sequence is also
illustrated by its presence in the anterior gradient-like proteins Nag
and Mag, which are involved in vertebrate limb generation [7].
Interestingly, these proteins also carry the single Cys residue,
exactly as in AGR2. Our observation that AGR2 was not retained
in CHO-K1 cells when this Cys was replaced by Ser suggests that
the Cys could be coupled to ER retention. One can speculate that
the KTEL mediated ER retention is linked to the presence of a
free Cys and that modification or binding of this Cys to another
molecule allow AGR2 to exit from the ER. Of course other
alternatives, as for example misfolding AGR2, may explain
secretion of the C81S. Studies of the role of a single Cys combined
with a C-terminal KDEL sequence requires further studies.
Our studies of the gastrointestinal tract show that Agr2 is
present in mucus throughout the entire gastrointestinal tract. The
role of Agr2 in the mucus is not understood, but that its molar
levels are similar or maybe even higher than the Muc2 mucin
strongly suggest an extracellular function. This hypothesis is
supported by AGR2 involvement in cancer progression or in
normal mammary gland lobular development as controlling
cellular development and regeneration [8,9]. However, this
function is probably complex and cell specific, as the absence of
Agr2 caused hyperplasia of specific cells in the glandular stomach
and for the Paneth cells, but not for other intestinal cells [13,14].
The structural studies also suggest that AGR2 have yet unknown
cell binding sites [10].
To conclude, AGR2 has complex effects on the ER morphology
and its single Cys amino acid may be involved in the control of
AGR2 retention in the ER. The high concentration of Agr2 in the
gastrointestinal mucus suggests extracellular functions.
Figure 6. AGR2 detection in CHO-K1 cells transfected with
plasmids encoding the human AGR2 and mutated versions. (A)
Cell lysate and (B) spent culture media of the transfected cells separated
on a reducing SDS-PAGE and Western blotted. Band intensities of AGR2
normalized to the strongest band (C81S) in the blots of three replicates
in (A) and (B) are ahown as a histogram in Fig. S3. All the AGR2 forms
were found in the lysate at the expected size. The truncated AGR2
(DKTEL) and the C81S were secreted out into the media. C. Loading
control for panel A. showing a-actin expression in corresponding lanes.
Band intensities normalized to the strongest band in the blot is noted in
the corresponding lane. (D) AGR2 transfected CHO-K1 cells immuno-
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Supporting Information
Figure S1 Histogram of band intensities corresponding
to immunoblotted gel in Fig 2A. Intensities were measured
from three replicate blots and normalized to the strongest band in
the blot (clone #4). Annotations a in legend to Fig. 2. Error bars
represent standard deviation.
(TIF)
Figure S2 Immunostaining of distal colon of Agr22/2
mice. Pictures show three different animals at two separate
locations. Green panel represent mature Muc2 (stained with
antiserum anti-MUC2C3) and the blue panel to the right
represent DNA staining (DAPI). In all the Agr22/2 sections,
small blue dots and rods likely represent bacteria found
throughout the sparsely mucus. No pronounced inner mucus
layer devoid of bacteria can be seen as found for the Agr2+/+ and
Agr2+/2 animals (Fig 4). The gap between the mucus and
epithelia is largely due to shrinkage during fixation. Scale bar
10 mm.
(TIF)
Figure S3 Histogram corresponding to immunoblotted
gels reproduced in Fig. 6A and Fig. 6B. Band intensities
measured from three replicate blots and normalized to the
strongest band (C81S). Annotation as in legend to Fig. 6. Error
bars represent standard deviation.
(TIF)
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